SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-15-002913
Filing Date
2015-08-27
Accepted
2015-08-27 15:41:55
Documents
1
Period of Report
2015-08-26

Document Format Files

Seq Description Document Type Size
1 form4-08272015_120847.html 4  
1 form4-08272015_120847.xml 4 3894
  Complete submission text file 0001415889-15-002913.txt   5357
Mailing Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121
Business Address 11588 SORRENTO VALLEY ROAD SUITE 20 SAN DIEGO CA 92121 8582599405
MABVAX THERAPEUTICS HOLDINGS, INC. (Issuer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11588 SORRENTO VALLEY ROAD, SUITE 20 SAN DIEGO CA 92121
Business Address
Ravetch Jeffrey V. (Reporting) CIK: 0001612051 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-31265 | Film No.: 151078719